Leukemia
In the clinical field of medicine, leukemia is also called blood cancer and belongs to the category of malignant tumors. It is mainly divided into two types: acute leukemia and chronic leukemia. The difference is the speed and degree of onset. Leukemia is deteriorating faster, and it is often difficult to cure once it has leukemia. Adolescents are more frequent people with leukemia, so parents should always pay attention to the child’s physical condition and clearly distinguish the early symptoms of leukemia.
So what are the symptoms of leukemia?
1. Fever persists
Acute leukemia usually occurs among adolescents, the onset is very rapid, and the treatment time of the disease is very short, often only a few months. Therefore, once the child has a fever, he should be vigilant. The cause of fever is mostly an infection. For example, caused by pneumonia, stomatitis, or ear inflammation, it may sometimes be the symptoms of acute leukemia itself, without any other concomitant infection.
2. Abnormal bleeding
Leukemia patients may bleed from all parts of the body, such as the gums, skin, ear, and even the retina. The most common one is nosebleeds. Sometimes women have excessive menstrual periods, or they may be the first sign of leukemia..
3. Anemia
Patients with leukemia may first develop myelodysplastic syndrome and then slowly develop leukemia. The bone marrow is the main part of the body’s hematopoiesis. Therefore, patients may have anemia, weakness, paleness, etc. due to insufficient hematopoiesis. Symptoms such as palpitations, shortness of breath, and swollen lower extremities may also occur. Patients with various types of leukemia are likely to have signs of anemia, and usually the elderly are more prone to anemia.
4. Bone and joint pain
Leukemia patients suffer from bone pain and joint pain due to the infiltration of the bone and periosteum. The pain can be distributed in the limbs; it can also be diffused in the back; or local joint pain may occur. Bone and joint pain is also one of the significant manifestations of leukemia. If sudden joint and bone pain is unexplained, it is likely that you have leukemia.
5. Enlargement of liver, spleen and lymph nodes
Fifty percent of patients with leukemia will have symptoms of hepatospleen and lymphadenopathy, and acute lymphoblastic leukemia has the most obvious lymphadenopathy. The swollen lymph nodes are usually soft or medium-hard, with a smooth surface, no pain when pressed, and no adhesions.
6. Lesions on the skin and mucous membranes
The skin damage of leukemia patients manifests as nodules, lumps, and spots. Mucosal lesions refer to the swelling and ulcers of the oral mucosa, nasal mucosa, and respiratory mucosa. Pay attention to distinguish them from general ulcer diseases.
Leukemia is mainly caused by the increase of red blood cells and platelets in patients, and abnormal bone marrow, mainly affected by environmental factors and genetic factors. Therefore, it is recommended that patients adjust their daily diet to include more blood and nourishing foods, enhance bone health, and help prevent leukemia.
Susan Hau is a distinguished researcher in the field of cancer cell therapy, with a particular focus on T cell-based approaches and cancer vaccines. Her work spans several innovative treatment modalities, including CAR T-cell therapy, TIL (Tumor-Infiltrating Lymphocyte) therapy, and NK (Natural Killer) cell therapy.
Hau's expertise lies in cancer cell biology, where she has made significant contributions to understanding the complex interactions between immune cells and tumors.
Her research aims to enhance the efficacy of immunotherapies by manipulating the tumor microenvironment and exploring novel ways to activate and direct immune responses against cancer cells.
Throughout her career, Hau has collaborated with leading professors and researchers in the field of cancer treatment, both in the United States and China.
These international experiences have broadened her perspective and contributed to her innovative approach to cancer therapy development.
Hau's work is particularly focused on addressing the challenges of treating advanced and metastatic cancers. She has been involved in clinical trials evaluating the safety and efficacy of various immunotherapy approaches, including the promising Gamma Delta T cell therapy.
